Related Experiment Video

Updated: May 28, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Classification of cirrhosis: the clinical use of HVPG measurements

Agustín Albilllos1, Guadalupe Garcia-Tsao

  • 1Department of Gastoenterology and Hepatology, Hospital Ramón y Cajal, Madrid, Spain. aalbillosm@meditex.es

Disease Markers
|November 3, 2011
PubMed

Insights

Cirrhosis is now viewed as a dynamic, potentially reversible condition. Measuring hepatic venous pressure gradient (HVPG) helps stage cirrhosis, predict outcomes, and guide treatment for compensated and decompensated forms.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Cirrhosis is increasingly recognized as a dynamic and potentially reversible liver disease.
  • It presents as two distinct clinical entities: compensated and decompensated cirrhosis, each with unique prognostic factors.
  • Portal hypertension is a key feature of cirrhosis progression.

Purpose of the Study:

  • To highlight the modern understanding of cirrhosis as a dynamic process.
  • To emphasize the distinct prognoses and survival predictors for compensated and decompensated cirrhosis.
  • To underscore the role of hepatic venous pressure gradient (HVPG) measurement in stratifying disease severity and guiding management.

Main Methods:

  • Review of the current understanding of cirrhosis pathophysiology and clinical presentation.
  • Discussion of the significance of portal hypertension in disease progression.
  • Emphasis on the utility of hepatic venous pressure gradient (HVPG) measurements.

Main Results:

  • Cirrhosis is characterized by two stages: compensated and decompensated.
  • Prognosis and survival predictors differ significantly between these two stages.
  • HVPG measurement effectively stratifies patients into stages with defined outcomes.

Conclusions:

  • Cirrhosis should be viewed as a dynamic and potentially reversible condition.
  • HVPG measurement is crucial for staging cirrhosis, predicting prognosis, and informing management strategies.
  • Understanding compensated and decompensated cirrhosis is key to effective patient care.

More Related Videos

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

Contrast-Enhanced Subharmonic Aided Pressure Estimation (SHAPE) Using Ultrasound Imaging with a Focus on Identifying Portal Hypertension06:20

Contrast-Enhanced Subharmonic Aided Pressure Estimation (SHAPE) Using Ultrasound Imaging with a Focus on Identifying Portal Hypertension

Published on: December 5, 2020

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...